MAP1LC3A and neoplasm: Inhibition of LC3‐associated phagocytosis (LAP) in myeloid cells caused a proinflammatory phenotype in TAMs, and increased phagocytosis of dying tumour cells resulting in increased tumour control, suggesting that LAP increases immune tolerance [110].